The effect of instituting a prehospital-discharge newborn bilirubin screening program in an 18-hospital health system

Pediatrics

Volumn 117, Issue 5, 2006, Pages

  Eggert, Larry D ^a,c   Wiedmeier, Susan E ^a,b   Wilson, Janie ^a   Christensen, Robert D ^a  

^a NICU Development Team   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c Dixie Regional Medical Center   (United States)

Author keywords

Hour specific bilirubin nomogram; Hyperbilirubinemia; Kernicterus; Neonatal jaundice; Universal bilirubin screening

Indexed keywords

BILIRUBIN;

ARTICLE; BILIRUBIN BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; EMERGENCY CARE; FOLLOW UP; GESTATION PERIOD; HEALTH CARE; HEALTH PROGRAM; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; HYPERBILIRUBINEMIA; INBORN ERROR OF METABOLISM; JAUNDICE; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SCREENING; NOMOGRAM; PRIORITY JOURNAL; BLOOD; CLINICAL TRIAL; KERNICTERUS; MULTICENTER STUDY; NEWBORN JAUNDICE;

BILIRUBIN; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN; KERNICTERUS; NEONATAL SCREENING; PATIENT READMISSION;

EID: 33646846603     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2005-1338     Document Type: Article

References (39)

1. Van Praagh R. Diagnosis of kernicterus in the neonatal period. Pediatrics. 1961;28:870-876
2. Connolly AM, Volpe JJ. Clinical features of bilirubin encephalopathy. Clin Perinatol. 1990;17:371-379
3. Hsia DY-Y, Allen FH Jr, Gellis SS, Diamond LK. Erythroblastosis fetalis. VIII. Studies of serum bilirubin in relation to kernicterus. N Engl J Med. 1952;247:668-671
4. Johnstom WH, Angara V, Baumal R, et al. Erythroblastosis fetalis and hyperbilirubinemia: a five-year follow-up with neurological, psychological, and audiological evaluation. Pediatrics. 1967;39:88-92
5. Bilirubin and brain injury. In: Volpe JJ, ed. Neonatal Neurology. Philadelphia, PA: WB Saunders; 2001:521-546
6. Brown AK, Johnson L. Loss of concern about jaundice and the reemergence of kernicterus in full-term infants in the era of managed care. In: Fanaroff AA, Klaus MH, eds. The Year Book of Neonatal and Perinatal Medicine. Philadelphia, PA: Mosby Yearbook; 1996:17-28
7. Penn AA, Enzmann DR, Hahn JS, Stevenson DK. Kernicterus in a full term infant. Pediatrics. 1994;93:1003-1006
8. Maisels MJ, Newman TB. Kernicterus in otherwise healthy, breast-fed term newborns. Pediatrics. 1995;96:730-733
9. Sola A. Changes in clinical practice and bilirubin encephalopathy in "healthy term newborns" [abstract]. Pediatr Res. 1995;37:145
10. MacDonald MG. Hidden risks: early discharge and bilirubin toxicity due to glucose-6-phosphate dehydrogenase deficiency. Pediatrics. 1995;96:734-738
11. Washington C, Ector W, Abbound K, Ohning B, Holding KR. Hemolytic jaundice due to G6PD deficiency causing kernicterus in newborn female. South Med J. 1995;88:776-779
12. Ebbesen F. Recurrence of kernicterus in term and near-term infants in Denmark. Acta Paediatr. 2000;89:1213-1217
13. Stanley TV. A case of kernicterus in New Zealand: a predictable tragedy? J Paediatr Child Health. 1997;33:451-453
14. Harris MC, Bernbaum JC, Polin JR, Zimmerman R, Polin RA. Developmental follow-up of breast-fed term and near-term infants with marked hyperbilirubinemia. Pediatrics. 2001;107:1075-1080
15. Johnson L, Brown AK. A pilot registry for acute and chronic kernicterus in term and near-term infants [abstract]. Pediatrics. 1999;104:736
16. Johnson LH, Bhutani VK, Brown AK. System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr. 2002;140:396-403
17. Bhutani VK, Johnson LH, Maisels MJ, et al. Kernicterus: epidemiological strategies for its prevention through systems-based approaches. J Perinatol. 2004;24:650-662
18. Joint Commission on Accreditation of Healthcare Organizations. Kernicterus threatens healthy newborns. Sentinel Event Alert. 2001;18:1-4
19. Centers for Disease Control and Prevention. Kernicterus in full-term infants: United States, 1994-1998. MMWR Morb Mortal Wkly Rep. 2001;50:491-494
20. National Quality Forum. A national framework for healthcare quality measurement and reporting: a consensus report. Available at: www.qualityforum.org/txframepublic.pdf. Accessed June 20, 2005
21. American Academy of Pediatrics, Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation [published correction appears in Pediatrics. 2004;114:1138]. Pediatrics. 2004;114:297-316
22. Bhutani VK, Johnson L, Sivieri E. Predictive ability of a pre-discharge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics. 1999;103:6-14
23. Newman TB, Xiong B, Gonzales VM, Escobar GJ. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med. 2000;154:1140-1147
24. Alpay F, Sarici SU, Tosuncuk HD, Serdar MA, Inanc N, Gokcay E. The value of first-day bilirubin measurement in predicting the development of significant hyperbilirubinemia in healthy term newborns. Pediatrics. 2000;106:1-6
25. Stevenson DK, Fanaroff A, Maisels J, et al. Prediction of hyperbilirubinemia in term and near-term newborn infants. Pediatrics. 2001;108:31-39
26. Dennery PA, Seidman DS, Stevenson DK. Neonatal hyperbilirubinemia. N Engl J Med. 2001;344:581-590
27. Braveman P, Egerter S, Pearl M, Marchi K, Miller C. Problems associated with early discharge of newborn infants: early discharge of newborns and mothers. A critical review of the literature. Pediatrics. 1995;96:716-726
28. Britton JR, Britton HL, Beebe SA. Early discharge of the term newborn: a continued dilemma. Pediatrics. 1994;94:291-295
29. Watchko JF, Oski FA. Bilirubin 20 mg/dL = vigintiphobia. Pediatrics. 1983;71:660-663
30. Newman TB, Masisel MJ. Does hyperbilirubinemia damage the brain of healthy full-term infants. Clin Perinatol. 1990;17:331-357
31. Newman TB, Maisels MJ. Evaluation and treatment of jaundice in the term newborn: a kinder, gentler approach. Pediatrics. 1992;89:809-818
32. Oski A. Hyperbilirubinemia in the term infant: an unjaundiced approach. Contemp Pediatr. 1992;April:148-152
33. American Academy of Pediatrics, Provisional Committee for Quality Improvement. Practice parameter: management of hyperbilirubinemia in the healthy term newborn [published correction appears in Pediatrics. 1995;95:458-61]. Pediatrics. 1994;94:558-565
34. Maisel MJ, Newman TB. Predicting hyperbilirubinemia in newborns: the importance of timing. Pediatrics. 1999;103:493-495
35. Newman TB, Escobar GJ, Gonzales VM, Armstrong MA, Gardner MN, Folck BF. Frequency of neonatal bilirubin testing and hyperbilirubinemia in a large health maintenance organization. Pediatrics. 1999;104:1198-1203
36. Lee KS, Perlman M, Ballantyne M, Elliott I. Association between duration of neonatal hospital stay and readmission rate. J Pediatr. 1995;127:758-766
37. Grupp-Phelan J, Taylor JA, Liu LL, Davis RL. The effect of early discharge and other factors on readmission rates of newborns. Arch Pediatr Adolesc Med. 1999;153:1283-1288
38. Maisels MJ, Kring E. Length of stay, jaundice, and hospital readmission. Pediatrics. 1998;101:995-998
39. Sarici SU, Serdar MA, Korkmaz A, et al. Incidence, course, and prediction of hyperbilirubinemia in near-term and term newborns. Pediatrics. 2004;113:775-780